XT Venture Capital

About

Portfolio · 2

Intratech Medical

Balloon Catheter Therapy for Treatment of Acute Myocardial Infarction

Led ★ 1 round Latest: 2007-12

Quiksee

Online Tour Technology

2 rounds $3.5M committed Latest: 2007-05

Investment activity

7 portfolio exits on record.

Q&A

What is XT Venture Capital's most recent exit?

XT Venture Capital's most recent exit was Cymbio, which was acquired by PayPal in January 2026. Another recent exit was Applied Spectral Imaging, acquired by ZYTOMICS in August 2025.

What are some of XT Venture Capital's recent investments?

XT Venture Capital recently invested in Orion Security, participating in their A Round in December 2024. They also invested in Localbird, which raised a Seed round in February 2025.

Which sectors does XT Venture Capital primarily focus on for investments?

XT Venture Capital shows a strong focus on Health Tech & Life Sciences, with 8 portfolio companies in this sector. They also have significant investments in Cyber Security and Business Software, each with 3 portfolio companies.

Can you name some of XT Venture Capital's notable portfolio companies?

XT Venture Capital's portfolio includes Beyeonics, a surgical visualization technology company that raised a $47.5M Series B, and NeuReality, which secured a $63M Series A for AI inference technology.

What is the typical investment stage for XT Venture Capital?

XT Venture Capital primarily invests in Seed, A Round, and B Round stages. According to startupim data, they have made 8 A Round investments and 3 Seed investments.

What was XT Venture Capital's largest exit by disclosed amount?

XT Venture Capital's largest exit by disclosed amount was Checkmarx, which was acquired for $1.15 billion in March 2020 by Hellman & Friedman.

Who are the managing directors at XT Venture Capital?

The managing directors at XT Venture Capital are Yoav Sebba and Assif Stoffman.

Where is XT Venture Capital headquartered?

XT Venture Capital is headquartered in Tel Aviv-Yafo, Israel.